10 Results for "

AC1 inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "AC1 inhibitor" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-101279
CAS No.: 133406-29-8
Purity:  99.11%
Target:  

Adenylate Cyclase

Research Areas:  

Neurological Disease

ST034307 is a potent and selective adenylyl cyclase 1 (AC1) inhibitor, with IC50 of 2.3 μM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128433
CAS No.: 349438-74-0
Purity:  99.00%
Target:  

Casein Kinase

Research Areas:  

Neurological Disease

CK1-IN-3 (compound 51) is a AC1 inhibitor with an IC50s 2.22 µM for CK-1δ .
loading...
    loading...
Cat. No.: HY-14425
CAS No.: 686301-48-4
Purity:  98.7%
Synonyms: HTS 09836; NB001
Target:  

Adenylate Cyclase

Research Areas:  

Neurological Disease

NB001 (HTS 09836) is an adenylcyclase 1 (AC1) inhibitor which has effect on neural and non-neural pain by modulating AC1 activity .
loading...
    loading...
Cat. No.: HY-145830
CAS No.: 2762422-55-7
Purity:  99.32%
Target:  

Adenylate Cyclase

Research Areas:  

Neurological Disease

AC1-IN-1 is a potent and selective Adenylyl cyclase type 1 (AC1) inhibitor with an IC50 of 0.54 μM. AC1-IN-1 displays modest antiallodynic effects in a mouse model of inflammatory pain .
loading...
    loading...
Cat. No.: HY-101863
CAS No.: 379218-90-3
Target:  

Adenylate Cyclase

Research Areas:  

Cardiovascular Disease

CB-6673567 is a selective AC1 inhibitor with an IC50 of 77 μM .CB-6673567blocks the choline-induced cAMP increase and can be used for cardiovascular diseases research .
loading...
    loading...
Cat. No.: HY-171279
CAS No.: 1177418-39-1
Research Areas:  

Inflammation/Immunology

Casein kinase 1δ-IN-29 (Compound 18) is the inhibitor for p38α and casein kinase 1 that inhibits p38α, CK1δ and CK1ε with IC50 of 0.041 µM, 0.005 µM and 0.447 µM, respectively. Casein kinase 1δ-IN-29 arrests cell cycle at subG1 phase, induces apoptosis in cell AC1-M88 .
loading...
    loading...
Cat. No.: HY-134373A
Research Areas:  

Infection

Bis-Cl-ANT-ATP (tetrasodium) is a fluorescent ATP derivative, which undergo spontaneous isomerization. Bis-Cl-ANT-ATP (tetrasodium) selectively inhibits B. pertussis Adenylyl Cyclase (AC) toxin CyaA over mammalian AC1, AC2, and AC5 (Kis = 16, 1,700, 2,400, and 1,600 nM, respectively). Bis-Br-ANT-ATP (tetrasodium) can be used in the study of whooping cough .
loading...
    loading...
Cat. No.: HY-101279R
CAS No.: 133406-29-8
ST034307 (Standard) is the analytical standard of ST034307 (HY-101279). This product is intended for research and analytical applications. ST034307 is a potent and selective adenylyl cyclase 1 (AC1) inhibitor, with IC50 of 2.3 μM.
loading...
    loading...
Cat. No.: HY-174151
CAS No.: 203923-65-3
Target:  

Topoisomerase Apoptosis

Research Areas:  

Cancer

XSJ110 is a potent irreversible topoisomerase I (Topo I) inhibitor with an IC50 value of 0.133 μM. XSJ110 blocks DNA topoisomerization, induces DNA double-strand breaks, and triggers cell cycle arrest at G0/G1 phase, inducing tumor cell apoptosis. XSJ110 is promising for research of ampullary carcinoma (AC) .
loading...
    loading...
Cat. No.: HY-160126
CAS No.: 2154373-60-9
Target:  

LXR

Research Areas:  

Others

27-Norcholestenoic acid is an inverse agonist of LXRβ and LXRα that decreases basal luciferase activity and inhibits agonist-induced transactivation. 27-Norcholestenoic acid induces conformational changes in the AF-2 domain that favor corepressor over coactivator recruitment, thereby destabilizing the active receptor conformation. 27-Norcholestenoic acid downregulates FASN and SREBP-1a/c gene expression .
loading...
    loading...